{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:14:31Z","timestamp":1795025671122,"version":"4.10.2"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-51304-x","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T06:02:47Z","timestamp":1724738567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Plasma proteomics of acute tubular injury"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0420-6570","authenticated-orcid":false,"given":"Insa M.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya L.","family":"Surapaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3458-0194","authenticated-orcid":false,"given":"Runqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3044-4335","authenticated-orcid":false,"given":"Dhairya","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Jin","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8460-0462","authenticated-orcid":false,"given":"Pascal","family":"Schlosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnar","family":"Palsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2589-7390","authenticated-orcid":false,"given":"Taesoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac E.","family":"Stillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0776-3030","authenticated-orcid":false,"given":"Daria","family":"Barwinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Barasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3066-2876","authenticated-orcid":false,"given":"Michael T.","family":"Eadon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4645-3614","authenticated-orcid":false,"given":"Tarek M.","family":"El-Achkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9537-9038","authenticated-orcid":false,"given":"Dennis G.","family":"Moledina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia E.","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie E.","family":"Claudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4162-9107","authenticated-orcid":false,"given":"Maja","family":"Lindenmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7175-5062","authenticated-orcid":false,"given":"Tobias B.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir V.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad H.","family":"Rovin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0783-0918","authenticated-orcid":false,"given":"Ian B.","family":"Stanaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha A.","family":"Sathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan K.","family":"Bhatraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4598-0669","authenticated-orcid":false,"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Kidney Precision Medicine Project","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4804-7583","authenticated-orcid":false,"given":"Eugene P.","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4430-6023","authenticated-orcid":false,"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4004-326X","authenticated-orcid":false,"given":"Sushrut S.","family":"Waikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"51304_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev-med-050214-013407","volume":"67","author":"A Zuk","year":"2016","unstructured":"Zuk, A. & Bonventre, J. V. Acute kidney injury. Annu Rev. Med 67, 293\u2013307 (2016).","journal-title":"Annu Rev. Med"},{"key":"51304_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.semnephrol.2016.05.005","volume":"36","author":"RK Hsu","year":"2016","unstructured":"Hsu, R. K. & Hsu, C. Y. The role of acute kidney injury in chronic kidney disease. Semin Nephrol. 36, 283\u2013292 (2016).","journal-title":"Semin Nephrol."},{"key":"51304_CR3","doi-asserted-by":"publisher","first-page":"F145","DOI":"10.1152\/ajprenal.00164.2016","volume":"311","author":"RL Chevalier","year":"2016","unstructured":"Chevalier, R. L. The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction. Am. J. Physiol. Ren. Physiol. 311, F145\u2013F161 (2016).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"51304_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev-physiol-052521-121841","volume":"84","author":"MS Balzer","year":"2022","unstructured":"Balzer, M. S., Rohacs, T. & Susztak, K. How many cell types are in the kidney and what do they do? Annu Rev. Physiol. 84, 507\u2013531 (2022).","journal-title":"Annu Rev. Physiol."},{"key":"51304_CR5","first-page":"2","volume":"20","author":"MS Matovinovi\u0107","year":"2009","unstructured":"Matovinovi\u0107, M. S. 1. Pathophysiology and classification of kidney diseases. Ejifcc 20, 2\u201311 (2009).","journal-title":"Ejifcc"},{"key":"51304_CR6","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1046\/j.1523-1755.1999.00721.x","volume":"56","author":"RE Gilbert","year":"1999","unstructured":"Gilbert, R. E. & Cooper, M. E. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 56, 1627\u20131637 (1999).","journal-title":"Kidney Int"},{"key":"51304_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2205951","volume":"45","author":"M Sun","year":"2023","unstructured":"Sun, M. et al. Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage. Ren. Fail 45, 2205951 (2023).","journal-title":"Ren. Fail"},{"key":"51304_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.semnephrol.2017.09.003","volume":"38","author":"GW Moeckel","year":"2018","unstructured":"Moeckel, G. W. Pathologic perspectives on acute tubular injury assessment in the kidney biopsy. Semin Nephrol. 38, 21\u201330 (2018).","journal-title":"Semin Nephrol."},{"key":"51304_CR9","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.ekir.2020.08.026","volume":"5","author":"Y Wen","year":"2020","unstructured":"Wen, Y., Yang, C., Menez, S. P., Rosenberg, A. Z. & Parikh, C. R. A systematic review of clinical characteristics and histologic descriptions of acute tubular injury. Kidney Int Rep. 5, 1993\u20132001 (2020).","journal-title":"Kidney Int Rep."},{"key":"51304_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/ckj\/sfaa142","volume":"14","author":"JP Gaut","year":"2021","unstructured":"Gaut, J. P. & Liapis, H. Acute kidney injury pathology and pathophysiology: a retrospective review. Clin. Kidney J. 14, 526\u2013536 (2021).","journal-title":"Clin. Kidney J."},{"key":"51304_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.7326\/M22-3617","volume":"176","author":"AN Muiru","year":"2023","unstructured":"Muiru, A. N. et al. Risk for chronic kidney disease progression after acute kidney injury: findings from the chronic renal insufficiency cohort study. Ann. Intern Med 176, 961\u2013968 (2023).","journal-title":"Ann. Intern Med"},{"key":"51304_CR12","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1681\/ASN.2013070758","volume":"25","author":"VS Sabbisetti","year":"2014","unstructured":"Sabbisetti, V. S. et al. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J. Am. Soc. Nephrol. 25, 2177\u20132186 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"51304_CR13","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/ndt\/gfw203","volume":"31","author":"SS Waikar","year":"2016","unstructured":"Waikar, S. S. et al. Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studies. Nephrol. Dial. Transpl. 31, 1460\u20131470 (2016).","journal-title":"Nephrol. Dial. Transpl."},{"key":"51304_CR14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41591-019-0415-5","volume":"25","author":"MA Niewczas","year":"2019","unstructured":"Niewczas, M. A. et al. A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes. Nat. Med 25, 805\u2013813 (2019).","journal-title":"Nat. Med"},{"key":"51304_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/MNH.0b013e328351a391","volume":"21","author":"T Isakova","year":"2012","unstructured":"Isakova, T. Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 21, 334\u2013340 (2012).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"51304_CR16","doi-asserted-by":"publisher","first-page":"29508","DOI":"10.3390\/ijms161226189","volume":"16","author":"M Bonomini","year":"2015","unstructured":"Bonomini, M. et al. Proteomic investigations into hemodialysis therapy. Int J. Mol. Sci. 16, 29508\u201329521 (2015).","journal-title":"Int J. Mol. Sci."},{"key":"51304_CR17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/ki.2015.150","volume":"88","author":"EL Tsalik","year":"2015","unstructured":"Tsalik, E. L. et al. Renal systems biology of patients with systemic inflammatory response syndrome. Kidney Int 88, 804\u2013814 (2015).","journal-title":"Kidney Int"},{"key":"51304_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40620-018-0556-5","volume":"32","author":"T Feldreich","year":"2019","unstructured":"Feldreich, T. et al. Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease. J. Nephrol. 32, 111\u2013119 (2019).","journal-title":"J. Nephrol."},{"key":"51304_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2215\/CJN.09380721","volume":"17","author":"IM Schmidt","year":"2022","unstructured":"Schmidt, I. M. et al. Circulating plasma biomarkers in biopsy-confirmed kidney disease. Clin. J. Am. Soc. Nephrol. 17, 27\u201337 (2022).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"51304_CR20","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.2215\/CJN.08780816","volume":"12","author":"AC Carlsson","year":"2017","unstructured":"Carlsson, A. C. et al. Use of proteomics to investigate kidney function decline over 5 years. Clin. J. Am. Soc. Nephrol. 12, 1226\u20131235 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"51304_CR21","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1093\/ndt\/gfv254","volume":"30","author":"G Glorieux","year":"2015","unstructured":"Glorieux, G. et al. New insights in molecular mechanisms involved in chronic kidney disease using high-resolution plasma proteome analysis. Nephrol. Dial. Transpl. 30, 1842\u20131852 (2015).","journal-title":"Nephrol. Dial. Transpl."},{"key":"51304_CR22","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.kint.2019.07.025","volume":"96","author":"M Kammer","year":"2019","unstructured":"Kammer, M. et al. Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetes. Kidney Int 96, 1381\u20131388 (2019).","journal-title":"Kidney Int"},{"key":"51304_CR23","doi-asserted-by":"crossref","unstructured":"Azuaje F., Kim S. Y., Perez Hernandez D., Dittmar G. Connecting Histopathology Imaging and Proteomics in Kidney Cancer through Machine Learning. J Clin Med. 2019;8.","DOI":"10.1101\/756288"},{"key":"51304_CR24","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/ki.2008.657","volume":"75","author":"S Sethi","year":"2009","unstructured":"Sethi, S. et al. Glomeruli of dense deposit disease contain components of the alternative and terminal complement pathway. Kidney Int. 75, 952\u2013960 (2009).","journal-title":"Kidney Int."},{"key":"51304_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1056\/NEJMra1214243","volume":"371","author":"LS Chawla","year":"2014","unstructured":"Chawla, L. S., Eggers, P. W., Star, R. A. & Kimmel, P. L. Acute kidney injury and chronic kidney disease as interconnected syndromes. N. Engl. J. Med 371, 58\u201366 (2014).","journal-title":"N. Engl. J. Med"},{"key":"51304_CR26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/ki.2015.314","volume":"89","author":"N Nowak","year":"2016","unstructured":"Nowak, N. et al. Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes. Kidney Int 89, 459\u2013467 (2016).","journal-title":"Kidney Int"},{"key":"51304_CR27","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson, E. et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One 9, e95192 (2014).","journal-title":"PLoS One"},{"key":"51304_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1053\/j.ajkd.2021.05.013","volume":"79","author":"IM Schmidt","year":"2022","unstructured":"Schmidt, I. M. et al. Plasma kidney injury molecule 1 in CKD: findings from the Boston Kidney Biopsy Cohort and CRIC studies. Am. J. Kidney Dis. 79, 231\u2013243.e231 (2022).","journal-title":"Am. J. Kidney Dis."},{"key":"51304_CR29","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1097\/TP.0000000000003299","volume":"105","author":"SG Mansour","year":"2021","unstructured":"Mansour, S. G. et al. Uromodulin to osteopontin ratio in deceased donor urine is associated with kidney graft outcomes. Transplantation 105, 876\u2013885 (2021).","journal-title":"Transplantation"},{"key":"51304_CR30","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1046\/j.1523-1755.2001.00032.x","volume":"60","author":"Y Xie","year":"2001","unstructured":"Xie, Y. et al. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 60, 1645\u20131657 (2001).","journal-title":"Kidney Int"},{"key":"51304_CR31","doi-asserted-by":"publisher","first-page":"eabm5900","DOI":"10.1126\/sciadv.abm5900","volume":"8","author":"FZ Khamissi","year":"2022","unstructured":"Khamissi, F. Z. et al. Identification of kidney injury released circulating osteopontin as causal agent of respiratory failure. Sci. Adv. 8, eabm5900 (2022).","journal-title":"Sci. Adv."},{"key":"51304_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/ndt\/gfq498","volume":"26","author":"JM Lorenzen","year":"2011","unstructured":"Lorenzen, J. M. et al. Osteopontin predicts survival in critically ill patients with acute kidney injury. Nephrol. Dial. Transpl. 26, 531\u2013537 (2011).","journal-title":"Nephrol. Dial. Transpl."},{"key":"51304_CR33","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1093\/ndt\/gfac173","volume":"38","author":"I Steinbrenner","year":"2023","unstructured":"Steinbrenner, I. et al. Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study. Nephrol. Dial. Transpl. 38, 1430\u20131438 (2023).","journal-title":"Nephrol. Dial. Transpl."},{"key":"51304_CR34","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.kint.2020.01.026","volume":"97","author":"H Zhu","year":"2020","unstructured":"Zhu, H. et al. Tenascin-C promotes acute kidney injury to chronic kidney disease progression by impairing tubular integrity via \u03b1v\u03b26 integrin signaling. Kidney Int 97, 1017\u20131031 (2020).","journal-title":"Kidney Int"},{"key":"51304_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nm.2989","volume":"19","author":"VS LeBleu","year":"2013","unstructured":"LeBleu, V. S. et al. Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat. Med 19, 227\u2013231 (2013).","journal-title":"Nat. Med"},{"key":"51304_CR36","doi-asserted-by":"publisher","first-page":"67748","DOI":"10.18632\/oncotarget.11682","volume":"7","author":"J Wan","year":"2016","unstructured":"Wan, J. et al. Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease. Oncotarget 7, 67748\u201367759 (2016).","journal-title":"Oncotarget"},{"key":"51304_CR37","doi-asserted-by":"publisher","first-page":"e7824","DOI":"10.1097\/MD.0000000000007824","volume":"96","author":"P Chen","year":"2017","unstructured":"Chen, P., Yang, Q., Li, X. & Qin, Y. Potential association between elevated serum human epididymis protein 4 and renal fibrosis: A systemic review and meta-analysis. Med. (Baltim.) 96, e7824 (2017).","journal-title":"Med. (Baltim.)"},{"key":"51304_CR38","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.2337\/dc20-0630","volume":"43","author":"K Ihara","year":"2020","unstructured":"Ihara, K. et al. Profibrotic circulating proteins and risk of early progressive renal decline in patients with type 2 diabetes with and without albuminuria. Diabetes Care 43, 2760\u20132767 (2020).","journal-title":"Diabetes Care"},{"key":"51304_CR39","doi-asserted-by":"crossref","unstructured":"Schmidt I. M., et al. Plasma Kidney Injury Molecule 1 in CKD: Findings From the Boston Kidney Biopsy Cohort and CRIC Studies. Am J Kidney Dis. 2021).","DOI":"10.1053\/j.ajkd.2021.05.013"},{"key":"51304_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ebiom.2017.05.016","volume":"20","author":"T Matsuhashi","year":"2017","unstructured":"Matsuhashi, T. et al. Mitochonic Acid 5 (MA-5) Facilitates ATP Synthase Oligomerization and Cell Survival in Various Mitochondrial Diseases. EBioMedicine 20, 27\u201338 (2017).","journal-title":"EBioMedicine"},{"key":"51304_CR41","doi-asserted-by":"publisher","first-page":"108668","DOI":"10.1016\/j.abb.2020.108668","volume":"696","author":"Y Fujita","year":"2020","unstructured":"Fujita, Y., Ito, M. & Ohsawa, I. Mitochondrial stress and GDF15 in the pathophysiology of sepsis. Arch. Biochem Biophys. 696, 108668 (2020).","journal-title":"Arch. Biochem Biophys."},{"key":"51304_CR42","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s40620-021-01020-2","volume":"34","author":"MV Perez-Gomez","year":"2021","unstructured":"Perez-Gomez, M. V. et al. Urinary Growth Differentiation Factor-15 (GDF15) levels as a biomarker of adverse outcomes and biopsy findings in chronic kidney disease. J. Nephrol. 34, 1819\u20131832 (2021).","journal-title":"J. Nephrol."},{"key":"51304_CR43","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.kint.2022.02.028","volume":"101","author":"L Vali\u00f1o-Rivas","year":"2022","unstructured":"Vali\u00f1o-Rivas, L. et al. Growth differentiation factor-15 preserves Klotho expression in acute kidney injury and kidney fibrosis. Kidney Int 101, 1200\u20131215 (2022).","journal-title":"Kidney Int"},{"key":"51304_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejim.2023.01.026","volume":"110","author":"Z Zhou","year":"2023","unstructured":"Zhou, Z. et al. Circulating GDF-15 in relation to the progression and prognosis of chronic kidney disease: A systematic review and dose-response meta-analysis. Eur. J. Intern Med 110, 77\u201385 (2023).","journal-title":"Eur. J. Intern Med"},{"key":"51304_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2023.02.003","volume":"114","author":"C Delrue","year":"2023","unstructured":"Delrue, C., Speeckaert, R., Delanghe, J. R. & Speeckaert, M. M. Growth differentiation factor 15 (GDF-15) in kidney diseases. Adv. Clin. Chem. 114, 1\u201346 (2023).","journal-title":"Adv. Clin. Chem."},{"key":"51304_CR46","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.cell.2019.07.033","volume":"178","author":"HH Luan","year":"2019","unstructured":"Luan, H. H. et al. GDF15 is an inflammation-induced central mediator of tissue tolerance. Cell 178, 1231\u20131244.e1211 (2019).","journal-title":"Cell"},{"key":"51304_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00902-5","volume":"7","author":"P Abulizi","year":"2017","unstructured":"Abulizi, P. et al. Growth differentiation factor-15 deficiency augments inflammatory response and exacerbates septic heart and renal injury induced by lipopolysaccharide. Sci. Rep. 7, 1037 (2017).","journal-title":"Sci. Rep."},{"key":"51304_CR48","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41574-021-00529-7","volume":"17","author":"D Wang","year":"2021","unstructured":"Wang, D. et al. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat. Rev. Endocrinol. 17, 592\u2013607 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"51304_CR49","doi-asserted-by":"publisher","first-page":"e021661","DOI":"10.1161\/JAHA.121.021661","volume":"10","author":"T Sen","year":"2021","unstructured":"Sen, T. et al. Association between circulating GDF-15 and cardio-renal outcomes and effect of canagliflozin: results from the CANVAS trial. J. Am. Heart Assoc. 10, e021661 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"51304_CR50","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1681\/ASN.2019090876","volume":"31","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Renoprotective and immunomodulatory effects of GDF15 following AKI invoked by ischemia-reperfusion injury. J. Am. Soc. Nephrol. 31, 701\u2013715 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"51304_CR51","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1681\/ASN.0000000000000108","volume":"34","author":"E Kiernan","year":"2023","unstructured":"Kiernan, E. et al. Alterations in the circulating proteome associated with albuminuria. J. Am. Soc. Nephrol. 34, 1078\u20131089 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"51304_CR52","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1681\/ASN.2020111607","volume":"32","author":"ME Grams","year":"2021","unstructured":"Grams, M. E. et al. Proteins associated with risk of kidney function decline in the general population. J. Am. Soc. Nephrol. 32, 2291\u20132302 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"51304_CR53","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1182\/blood-2014-11-609016","volume":"125","author":"T Renn\u00e9","year":"2015","unstructured":"Renn\u00e9, T. The vascular side of plasma kallikrein. Blood 125, 589\u2013590 (2015).","journal-title":"Blood"},{"key":"51304_CR54","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00125-020-05144-1","volume":"63","author":"MA H\u00e4rma","year":"2020","unstructured":"H\u00e4rma, M. A. et al. Decreased plasma kallikrein activity is associated with reduced kidney function in individuals with type 1 diabetes. Diabetologia 63, 1349\u20131354 (2020).","journal-title":"Diabetologia"},{"key":"51304_CR55","doi-asserted-by":"publisher","first-page":"e1010139","DOI":"10.1371\/journal.pgen.1010139","volume":"18","author":"Y Cheng","year":"2022","unstructured":"Cheng, Y. et al. Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study. PLoS Genet 18, e1010139 (2022).","journal-title":"PLoS Genet"},{"key":"51304_CR56","doi-asserted-by":"publisher","first-page":"e0215617","DOI":"10.1371\/journal.pone.0215617","volume":"14","author":"N Moradi","year":"2019","unstructured":"Moradi, N. et al. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function. PLoS One 14, e0215617 (2019).","journal-title":"PLoS One"},{"key":"51304_CR57","doi-asserted-by":"publisher","first-page":"22352","DOI":"10.1002\/jcp.28801","volume":"234","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. C1q\/tumor necrosis factor-related protein-3 improves renal fibrosis via inhibiting notch signaling pathways. J. Cell Physiol. 234, 22352\u201322364 (2019).","journal-title":"J. Cell Physiol."},{"key":"51304_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2022.106247","volume":"149","author":"C Du","year":"2022","unstructured":"Du, C. et al. C1q\/tumour necrosis factor-related protein-3 alleviates high-glucose-induced lipid accumulation and necroinflammation in renal tubular cells by activating the adenosine monophosphate-activated protein kinase pathway. Int J. Biochem Cell Biol. 149, 106247 (2022).","journal-title":"Int J. Biochem Cell Biol."},{"key":"51304_CR59","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1159\/000508639","volume":"144","author":"R Inagi","year":"2020","unstructured":"Inagi, R. The implication of organelle cross talk in AKI. Nephron 144, 634\u2013637 (2020).","journal-title":"Nephron"},{"key":"51304_CR60","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1681\/ASN.2017121260","volume":"29","author":"A Srivastava","year":"2018","unstructured":"Srivastava, A. et al. The prognostic value of histopathologic lesions in native kidney biopsy specimens: results from the Boston Kidney Biopsy Cohort study. J. Am. Soc. Nephrol. 29, 2213\u20132224 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"51304_CR61","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.kint.2020.08.039","volume":"99","author":"IH de Boer","year":"2021","unstructured":"de Boer, I. H. et al. Rationale and design of the kidney precision medicine project. Kidney Int 99, 498\u2013510 (2021).","journal-title":"Kidney Int"},{"key":"51304_CR62","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1016\/j.jacc.2021.04.035","volume":"77","author":"JD Wright","year":"2021","unstructured":"Wright, J. D. et al. The ARIC (Atherosclerosis Risk In Communities) study: JACC Focus Seminar 3\/8. J. Am. Coll. Cardiol. 77, 2939\u20132959 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"51304_CR63","doi-asserted-by":"publisher","first-page":"e0945","DOI":"10.1097\/CCE.0000000000000945","volume":"5","author":"NA Sathe","year":"2023","unstructured":"Sathe, N. A. et al. Biomarker signatures of severe acute kidney injury in a critically Ill cohort of covid-19 and non-covid-19 acute respiratory illness. Crit. Care Explor 5, e0945 (2023).","journal-title":"Crit. Care Explor"},{"key":"51304_CR64","doi-asserted-by":"publisher","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold, L. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One 5, e15004 (2010).","journal-title":"PLoS One"},{"key":"51304_CR65","doi-asserted-by":"publisher","first-page":"682","DOI":"10.2215\/CJN.07650713","volume":"9","author":"ME Grams","year":"2014","unstructured":"Grams, M. E. et al. Performance and limitations of administrative data in the identification of AKI. Clin. J. Am. Soc. Nephrol. 9, 682\u2013689 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"51304_CR66","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker, L. A. et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N. Engl. J. Med 385, 1737\u20131749 (2021).","journal-title":"N. Engl. J. Med"},{"key":"51304_CR67","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-023-05769-3","volume":"619","author":"BB Lake","year":"2023","unstructured":"Lake, B. B. et al. An atlas of healthy and injured cell states and niches in the human kidney. Nature 619, 585\u2013594 (2023).","journal-title":"Nature"},{"key":"51304_CR68","doi-asserted-by":"crossref","unstructured":"Barwinska D., et al. Molecular characterization of the human kidney interstitium in health and disease. Sci Adv. 2021;7.","DOI":"10.1126\/sciadv.abd3359"},{"key":"51304_CR69","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet 34, 267\u2013273 (2003).","journal-title":"Nat. Genet"},{"key":"51304_CR70","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51304-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51304-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51304-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T08:30:43Z","timestamp":1724747443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51304-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51304"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-51304-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"13 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.S.W. reports personal fees from Public Health Advocacy Institute, CVS, Roth Capital Partners, Kantum Pharma, Mallinckrodt, Wolters Kluewer, GE Health Care, GSK, Allena Pharmaceuticals, Mass Medical International, Barron and Budd (vs Fresenius), JNJ, Venbio, Strataca, Takeda, Cerus, Pfizer, Bunch and James, Harvard Clinical Research Institute (aka Baim), Oxidien, Sironax, Metro Biotechnology, Biomarin, and Bain. S.E.R reports grant support to Joslin from Bayer and AstraZeneca. In addition, she has participated as advisory member for Bayer and AstraZeneca. D.G.M. is named co-inventor on a pending patent, \u201cMethods and Systems for Diagnosis of Acute Interstitial Nephritis\u201d and is a co-founder of the diagnostics company Predict AIN, LLC.\u00a0Y.W.\u00a0reports being an employee of Genentech and having stock and stock options in Roche at the time of final manuscript revision. The remaining authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7368"}}